Has the fever broken for the high momentum stocks? Nvidia running out of steam this week, as some other high fliers also pull back. Is this just a bump in the road or the beginning of a summer slowdown? Plus Sarepta’s big surge. The biotech company getting expanded approval from the FDA for its muscular dystrophy drug. What the CEO says is next for the compa ... Show More
Aug 2021
Fed Chair Powell and Inflation Watch, Challenges for The Reopening Trade, The FDA and a Third Booster Shot, More Companies Revise Return to Work Plans, Micron As a "Red" Chip, Credit Card Spending Data Airlines Don't Want to Hear, and What to Expect From Disney Earnings
The morning after the Dow and S&P 500 posted record closing highs, Carl Quintanilla, Jim Cramer and David Faber led of the show with new wholesale inflation data: Producer prices for July coming in hotter than expected, rising one percent from the previous month and up 7.8-percen ... Show More
43m 28s
May 2021
The Reopening Trade: Uber's Revenue Miss, Vaccine Makers Tumble and Peloton After the Sell-off. Earnings Winners and Losers from ViacomCBS and PayPal to Etsy ... Plus "Reunited and It Feels So Good!"
Carl Quintanilla, Jim Cramer and David Faber took a wide-ranging look at the reopening trade: Uber shares under pressure after the company reported a revenue miss, vaccine makers such as Pfizer, BioNTech and Moderna saw their shares take a hit after the Biden Administration annou ... Show More
43m 54s
Aug 2021
The FDA Grants Full Approval to Pfizer's COVID Vaccine, Fed Chair Powell and Jackson Hole, Bitcoin Back Above $50K, Wall Street Firms' First Calls on Robinhood, "Gig Stocks" Slump on California Judge's Ruling, and Sir Richard Branson's Virgin Orbit to Go Public Via a SPAC Deal.
Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for the markets this week in light of the big news of the morning: The FDA officially granting full approval to the Pfizer/BioNTech COVID-19 vaccine. The anchors discussed what this development could mean for the ... Show More
43m 27s
Aug 2021
Disney Beats the Street and Leads the Stock Market to Record Highs, the FDA's COVID Booster Shot Authorization and Companies’ Approaches to Vaccinations, What Airbnb and DoorDash’s Results Tell Us About the Reopening Trade, and the CEO of the U.S. Chamber of Commerce Talks Infrastructure.
Carl Quintanilla, Morgan Brennan and Mike Santoli led off the show with Disney, whose better-than-expected quarterly results drove the stock higher, leading the Dow and S&P 500 to new record intraday highs. The anchors reacted to what Disney CEO Bob Chapek's told CNBC about Disne ... Show More
43m 46s
Dec 2021
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ... Show More
38m 7s
Jun 2021
Inflation rotation, green growing pains and a soda snub
The inflation trade is collapsing today, as the Fed gets a little more aggressive. We’ll tell you what moves to make right now.
Plus, a lot of investors have been piling into ESG stocks lately. But what exactly IS an ESG stock? We’ll define it for you.
And, in today’s ‘star-stu ... Show More
44m 51s
Jan 2024
20VC: Predictions for 2024: What Happens to Early Stage VC Funding, Do a Load of Venture Funds Die, What do LPs Do in 2024, Does Figma Kill the M&A Market, Will IPOs Comeback & What Does a Trump Administration do for Startups with Jason Lemkin @ SaaStr
<p><!-- wp:paragraph --></p> <p>Joining Harry in the hot seat today is <a href= "https://www.thetwentyminutevc.com/venture-broken/">Jason Lemkin</a>, Founder @ <a href= "https://coda.io/@jasonmlemkin/saastrfund/">SaaStr</a> and one of the OG SaaS investors of the last decade. The ... Show More
1h 11m